INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
CJ

Chakma Justin

Chief Business OfficerCIK 0001951238

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 2
Max Insider Score42
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
CJ
Chakma JustinChief Business Officer
SPRYARS Pharmaceuticals, Inc.
Option exercise
M$25K
30.0K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    ARS Pharmaceuticals, Inc.Chief Business Officer · Nov 14, 2025
31
CJ
Chakma JustinChief Business Officer
SPRYARS Pharmaceuticals, Inc.
Open-market sale
SELL
$267K
30.0K sh
Nov 12, 2025
Nov 14, 2025
traded Nov 12, 2025
+2d
SEC FORM 4

Evidence

42
CJ
Chakma JustinChief Business Officer
SPRYARS Pharmaceuticals, Inc.
Open-market sale
SELL$1.21M
136.4K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC FORM 4

Evidence

21
CJ
Chakma JustinChief Business Officer
SPRYARS Pharmaceuticals, Inc.
Option exercise
M—
30.0K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC FORM 4

Evidence